`

myNEO Therapeutics

Biotechnology Research

Specialities :

Immunotherapy

Big data

Cancer vaccine

Dark genome

And ai

Sign Up to View More

Revenue

11M - 100M

Total Funding

--

Size

11 - 50

About Us

myNEO Therapeutics is a distinguished biopharmaceutical powerhouse, dedicated to pioneer breakthrough immunotherapies to fight cancer. myNEO Therapeutics is leveraging its ImmunoEngine discovery platform to tap into novel promising tumor targets found in the dark genome named camyotopesTM which have the potential to unlock immunotherapy for large patient populations who currently do not respond. In parallel, the service angle of myNEO Therapeutics, myNEO Intelligence, assists biopharma companies in transforming their decision-making process from trial & error to data-driven decisions using an AI-powered platform. Deriving insights from its expansive library of clinical and molecular data, myNEO Intelligence maps the molecular profiling of cancer patients at an individual level and then correlates the different data points to make data-driven decisions across the drug development life cycle. myNEO Intelligence can identify novel targets and biomarkers, prioritize drug candidates ...

Sign Up to View More

Contact Information

Ghent , East Flanders , Belgium

Sign Up to View in Detail

myNEO Therapeutics Org Chart

No data available

Sign Up to View More Org Chart

Employees

Total Employees:
7

Top Contacts:
0

C-Level 0	VP - Level-
Director-	Manager-
Others8

Employees Working At myNEO Therapeutics

Bruno Fant

Chief Technology Officer

Emiel Evenepoel

Junior bioinformatician

Lien Lybaert

Chief Development Officer

Gitta Boons

Principal Bioinformatician

Bert Coessens

Chief Operating Officer

Sign Up to View More Employees of myNEO Therapeutics

myNEO Therapeutics Email Formats

No data available

Frequently Asked Questions About myNEO Therapeutics

What does Myneo therapeutics do?+

myNEO Therapeutics is a distinguished biopharmaceutical powerhouse, dedicated to pioneer breakthrough immunotherapies to fight cancer. myNEO Therapeutics is leveraging its ImmunoEngine discovery platform to tap into novel promising tumor targets found in the dark genome named camyotopesTM which have the potential to unlock immunotherapy for large patient populations who currently do not respond. In parallel, the service angle of myNEO Therapeutics, myNEO Intelligence, assists biopharma companies in transforming their decision-making process from trial & error to data-driven decisions using an AI-powered platform. Deriving insights from its expansive library of clinical and molecular data, myNEO Intelligence maps the molecular profiling of...

What are Myneo therapeutics's specialties? +

Immunotherapy,big data,cancer vaccine,dark genome,and ai

What is Myneo therapeutics's industry? +

Myneo therapeutics operates in the Biotechnology research industry.

What is Myneo therapeutics's revenue? +

Myneo therapeutics's revenue is 11m - 100m

What is Myneo therapeutics's company size? +

Myneo therapeutics has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map

Get Started With Clodura

Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Sign Up For Free

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Sign Up For Free

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.

Sign Up For Free